Skip to content

Inoperable oesophageal cancer - stent or percutaneous endoscopically placed gastrostomy (PEG). Randomised trial to compare the risks and benefits of expanding metallic stent and PEG in inoperable oesophageal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN95850244
Enrollment
40
Registered
2003-09-12
Start date
2000-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Oesophageal Cancer Oesophageal

Interventions

1. Oesophageal stent 2. PEG Please note that this trial was stopped due to participant recruitment issues.

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 20 patients for each study arm.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Survival and quality of life.

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026